[Metabolic disorders caused by intravenous administration of sorbitol or fructose].
D000138:Acidosis; D000255:Adenosine Triphosphate / Q000378:metabolism; D000284:Administration, Oral; D005632:Fructose / Q000009:adverse effects*; D006073:Gout; D006801:Humans; D006949:Hyperlipidemias; D000860:Hypoxia; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases; D008659:Metabolic Diseases / Q000139:chemically induced*; D013012:Sorbitol / Q000009:adverse effects*; D014280:Triglycerides / Q000378:metabolism
D014280:Triglycerides; D005632:Fructose; D013012:Sorbitol; D000255:Adenosine Triphosphate
Stoffwechselstörungen durch intravenöse Gabe von Fructose oder Sorbit.